AltPep
Dr. Fersht is a Professor at Cambridge University and the Medical Research Council. He has co-founded 3 biotech companies including Cambridge Antibody Technology. Alan serves on the Scientific Advisory Boards of HFS Research and others.
This person is not in the org chart
This person is not in any offices
AltPep
AltPep Corporation is a biomedical startup with a breakthrough approach for diagnosing and treating some of the world’s most intractable diseases: amyloid diseases. They are currently focusing on CNS disorders, in particular Alzheimer’s Disease (AD). They target and seek to neutralize the early toxic oligomers behind these amyloid diseases, which in the case of AD are due to aggregation of the Amyloid-beta peptide (Abeta).